Using Off‐Treatment Sequential Multiple Imputation for Binary Outcomes to Address Intercurrent Events Handled by a Treatment Policy Strategy

Read full text
Authors: Sunita Rehal, Nicky Best, Sarah Watts, Thomas Drury
Cited by: 0

Abstract

The estimand framework proposes different strategies to address intercurrent events. The treatment policy strategy seems to be the most favoured as it is closely aligned with the pre-addendum intention-to-treat principle. All data for all patients should ideally be collected; however, in reality patients may withdraw from a study leading to missing data. This needs to be dealt with as part of the estimation. A common intercurrent event we focus on is treatment discontinuation. Several areas of research have been conducted exploring models to estimate the estimand when intercurrent events are handled using a treatment policy strategy; however, the research is limited for binary endpoints. We explore different retrieved dropout models, where post-intercurrent event, the observed data can be used to multiply impute the missing post-intercurrent event data. We compare our proposed models to a simple imputation model that makes no distinction between the pre- and post-intercurrent event data, and assess varying statistical properties through a simulation study. We then provide an example of how retrieved dropout models were used in practice for Phase 3 clinical trials in rheumatoid arthritis. From the models explored, we conclude that a simple retrieved dropout model including an indicator for whether or not the intercurrent event occurred is the most pragmatic choice. However, at least 50% of observed post-intercurrent event data is required for these models to work well. Therefore, the suitability of implementing this model in practice will depend on the amount of observed post-intercurrent event data available and missing data.

Fields of Study & Subjects

Statistical Methods in Clinical Trials Statistical Methods and Bayesian Inference Advanced Causal Inference Techniques

Publication details

Journal / source
Pharmaceutical Statistics
Volume
25
Issue
2
Pages
e70070–e70070
Publication date
6 February 2026
Language
EN